| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| R&D Expense | $645K | — | +89.0% |
| SG&A Expense | $1.6M | — | -4.4% |
| Operating Income | -$2.3M | — | -11.3% |
| Pre-tax Income | -$2.2M | — | -0.3% |
| Income Tax | -$23K | — | — |
| Net Income | -$2.2M | — | +0.7% |
| EPS (Basic) | -$0.51 | — | -325.0% |
| EPS (Diluted) | -$0.51 | — | -325.0% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $6.1M | +38.8% | +78.5% |
| Short-term Investments | $4.0M | +0.0% | — |
| Current Assets | $7.5M | -25.6% | +93.6% |
| Total Assets | $7.5M | -25.6% | +93.6% |
| Total Liabilities | $1.3M | -26.8% | -64.9% |
| Stockholders' Equity | $6.2M | -25.4% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$2.2M | — | -4.2% |
| Investing Cash Flow | $4.0M | — | — |
| Financing Cash Flow | -$92K | — | -102.0% |
| +4389.7% |